Technical Analysis for VNRX - VolitionRX Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.62 | 3.89% | 0.02 |
Earnings due: May 8
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Expansion Breakdown | Bearish Swing Setup | 3.89% | |
| Below Lower BB | Weakness | 3.89% | |
| Down 3 Days in a Row | Weakness | 3.89% | |
| Down 4 Days in a Row | Weakness | 3.89% | |
| Down 5 Days in a Row | Weakness | 3.89% | |
| Lower Bollinger Band Touch | Weakness | 3.89% |
| Alert | Time |
|---|---|
| 2x Volume Pace | about 16 hours ago |
| 1.5x Volume Pace | about 16 hours ago |
| Possible Pocket Pivot | about 16 hours ago |
| 60 Minute Opening Range Breakout | about 18 hours ago |
| Rose Above Previous Day's High | about 19 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/08/2024
VolitionRX Limited Description
VolitionRX Limited, a development stage life sciences company, focuses on developing cancer detection blood tests for detecting and diagnosing cancer and other diseases. It develops two blood tests in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer and nucleosomes containing specific histone variants. The company also develops nine blood tests in the NuQ-M family to detect cancer by detecting nucleosomes containing modified histones, the proteins that package, and order DNA into nucleosomes; and five blood tests in the NuQ-A family to detect cancer by detecting nucleosome-protein adducts, as well as offers research kits. It develops HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help appropriate therapy; NuQ Endo endometriosis test; and NuQ clinical diagnostic products. VolitionRX Limited is based in Singapore.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Biology Disease Molecular Biology Genomics Diagnostic Products Blood Test Epigenetics Endometriosis Nucleotides
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.1 |
| 52 Week Low | 0.55 |
| Average Volume | 119,538 |
| 200-Day Moving Average | 0.96 |
| 50-Day Moving Average | 0.89 |
| 20-Day Moving Average | 0.72 |
| 10-Day Moving Average | 0.68 |
| Average True Range | 0.06 |
| RSI (14) | 29.58 |
| ADX | 34.92 |
| +DI | 7.67 |
| -DI | 27.77 |
| Chandelier Exit (Long, 3 ATRs) | 0.71 |
| Chandelier Exit (Short, 3 ATRs) | 0.76 |
| Upper Bollinger Bands | 0.82 |
| Lower Bollinger Band | 0.61 |
| Percent B (%b) | 0.01 |
| BandWidth | 28.42 |
| MACD Line | -0.07 |
| MACD Signal Line | -0.06 |
| MACD Histogram | -0.0064 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.69 | ||||
| Resistance 3 (R3) | 0.69 | 0.67 | 0.68 | ||
| Resistance 2 (R2) | 0.67 | 0.65 | 0.67 | 0.68 | |
| Resistance 1 (R1) | 0.64 | 0.64 | 0.66 | 0.64 | 0.67 |
| Pivot Point | 0.62 | 0.62 | 0.63 | 0.62 | 0.62 |
| Support 1 (S1) | 0.59 | 0.60 | 0.61 | 0.59 | 0.56 |
| Support 2 (S2) | 0.57 | 0.59 | 0.57 | 0.56 | |
| Support 3 (S3) | 0.54 | 0.57 | 0.55 | ||
| Support 4 (S4) | 0.54 |
